TY - JOUR
T1 - Contrasting Roles of Dopamine and Noradrenaline in the Motivational Properties of Social Play Behavior in Rats
AU - Achterberg, E.J.M.
AU - van Kerkhof, L.W.M.
AU - Servadio, Michela
AU - van Swieten, Maaike
AU - Houwing, Danielle J
AU - Aalderink, Mandy
AU - Driel, Nina V
AU - Trezza, Viviana
AU - Vanderschuren, L.J.M.J.
PY - 2016
Y1 - 2016
N2 - Social play behavior, abundant in the young of many mammalian species, is generally assumed to be important for social and cognitive development. Social play is highly rewarding, and as such, the expression of social play depends on its pleasurable and motivational properties. Since the motivational properties of social play have only been sporadically investigated, we developed a setup in which rats responded for social play under a progressive ratio schedule of reinforcement. Dopaminergic neurotransmission plays a key role in incentive motivational processes, and both dopamine and noradrenaline have been implicated in the modulation of social play behavior. Therefore, we investigated the role of dopamine and noradrenaline in the motivation for social play. Treatment with the psychostimulant drugs methylphenidate and cocaine increased responding for social play, but suppressed its expression during reinforced play periods. The dopamine reuptake inhibitor GBR-12909 increased responding for social play, but did not affect its expression, whereas the noradrenaline reuptake inhibitor atomoxetine decreased responding for social play as well as its expression. The effects of methylphenidate and cocaine on responding for social play were blocked by the dopamine receptor antagonist α-flupenthixol, but their play-suppressant effects were not altered. In contrast, pretreatment with the α2-adrenoceptor antagonist RX821002 prevented the play-suppressant effect of methylphenidate, but left its effect on responding for social play intact. These data demonstrate dissociable roles for dopamine and noradrenaline in social play behavior: dopamine stimulates the motivation for social play, whereas noradrenaline negatively modulates the motivation for social play and its expression.
AB - Social play behavior, abundant in the young of many mammalian species, is generally assumed to be important for social and cognitive development. Social play is highly rewarding, and as such, the expression of social play depends on its pleasurable and motivational properties. Since the motivational properties of social play have only been sporadically investigated, we developed a setup in which rats responded for social play under a progressive ratio schedule of reinforcement. Dopaminergic neurotransmission plays a key role in incentive motivational processes, and both dopamine and noradrenaline have been implicated in the modulation of social play behavior. Therefore, we investigated the role of dopamine and noradrenaline in the motivation for social play. Treatment with the psychostimulant drugs methylphenidate and cocaine increased responding for social play, but suppressed its expression during reinforced play periods. The dopamine reuptake inhibitor GBR-12909 increased responding for social play, but did not affect its expression, whereas the noradrenaline reuptake inhibitor atomoxetine decreased responding for social play as well as its expression. The effects of methylphenidate and cocaine on responding for social play were blocked by the dopamine receptor antagonist α-flupenthixol, but their play-suppressant effects were not altered. In contrast, pretreatment with the α2-adrenoceptor antagonist RX821002 prevented the play-suppressant effect of methylphenidate, but left its effect on responding for social play intact. These data demonstrate dissociable roles for dopamine and noradrenaline in social play behavior: dopamine stimulates the motivation for social play, whereas noradrenaline negatively modulates the motivation for social play and its expression.
KW - social play behavior
KW - dopamine
KW - noradrenaline
KW - operant conditioning
KW - incentive motivation
U2 - 10.1038/npp.2015.212
DO - 10.1038/npp.2015.212
M3 - Article
SN - 0893-133X
VL - 41
SP - 858
EP - 868
JO - Neuropsychopharmacology
JF - Neuropsychopharmacology
IS - 3
ER -